Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PRA Health Sciences, Inc. | EVP & CFO | Common Stock | 0 | $169.75 | Jul 1, 2021 | Direct | |
PRA Health Sciences, Inc. | EVP & CFO | Restricted Stock Unit | 0 | Jul 1, 2021 | Direct | ||
PRA Health Sciences, Inc. | EVP & CFO | Stock Option (Right to Buy) | 0 | Jul 1, 2021 | Direct | ||
Syneos Health, Inc. | Chief Financial Officer | Class A Common Stock | 0 | $43.00 | Sep 28, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SYNH | Syneos Health, Inc. | Sep 28, 2023 | 1 | $0 | 4 | Sep 28, 2023 | Chief Financial Officer |
SYNH | Syneos Health, Inc. | Jul 17, 2023 | 1 | $0 | 4 | Jul 18, 2023 | Chief Financial Officer |
SYNH | Syneos Health, Inc. | Jul 1, 2023 | 0 | $0 | 3 | Jul 7, 2023 | Chief Financial Officer |
PRAH | PRA Health Sciences, Inc. | Jul 1, 2021 | 8 | $0 | 4 | Jul 1, 2021 | EVP & CFO |
PRAH | PRA Health Sciences, Inc. | Jun 17, 2021 | 10 | -$4.27M | 4 | Jun 21, 2021 | EVP & CFO |
PRAH | PRA Health Sciences, Inc. | Jun 15, 2021 | 3 | -$1.23M | 4/A | Jun 30, 2021 | EVP & CFO |
PRAH | PRA Health Sciences, Inc. | Jun 1, 2021 | 6 | -$372K | 4 | Jun 3, 2021 | EVP & CFO |